Asthma in Infants and Children

Clinical Cornerstone

Volumn 8, Issue 4, 2008, Pages 44-61

  Chipps, Bradley E ^a  

^a Capital Allergy and Respiratory Disease Center Sacramento   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROFLUOROCARBON; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUORINATED HYDROCARBON; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PLACEBO; SALBUTAMOL; THEOPHYLLINE; TOBACCO SMOKE;

ADD ON THERAPY; ADRENAL INSUFFICIENCY; AIR POLLUTION; ANAPHYLAXIS; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CARDIOVASCULAR DISEASE; CHILD; CHILD HEALTH CARE; CHRONIC DISEASE; CLINICAL TRIAL; COCKROACH; COUGHING; DANDER; DAY CARE; DERMATOPHAGOIDES; DISEASE CONTROL; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; FACE MASK; FAMILY SIZE; GENETIC PREDISPOSITION; GROWTH DISORDER; HEALTH CARE SYSTEM; HEREDITY; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INFANT; INJECTION SITE REACTION; LONG TERM CARE; LOW BIRTH WEIGHT; LOW DRUG DOSE; LUNG FUNCTION; MEDICAL ASSESSMENT; MEDICAL RESEARCH; METERED DOSE INHALER; MOULD; NEBULIZER; OBESITY; PARASITOSIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POLLEN; PRACTICE GUIDELINE; PREVALENCE; RACE DIFFERENCE; RESPIRATORY TRACT INFECTION; RISK BENEFIT ANALYSIS; RISK FACTOR; SELF CARE; SENSITIZATION; SIDE EFFECT; SOCIAL STATUS; SYMPTOM; TH1 CELL; TH2 CELL; THRUSH; TREMOR; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; WHEEZING;

ASTHMA; CHILD; HUMANS; INFANT; PRACTICE GUIDELINES AS TOPIC;

EID: 49349116153     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(08)80012-9     Document Type: Article

References (49)

1. American Lung Association. Trends in asthma morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services July 2006.
2. (2007). http://www.lungusa.org April 9, Accessed
3. McDaniel M., Paxson C., and Waldfogel J. Racial disparities in childhood asthma in the United States: Evidence from the National Health Interview Survey, 1997 to 2003. Pediatrics 117 (2006) 868-877
4. United States Environmental Protection Agency.
5. (2006). http://www.epa.gov/ebtpages/humahealtheffectsasthma.html November 21, Accessed
6. Illi S., von Mutius E., Lau S., et al., For the Multicentre Allergy Study (MAS) group. Perennial allergen sensitisation early in life and chronic asthma in children: A birth cohort study. Lancet 368 (2006) 763-770
7. Reed C.E. The natural history of asthma. J Allergy Clin Immunol 118 (2006) 543-548
8. Sears M.R., Greene J.M., Willan A.R., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349 (2003) 1414-1422
9. Sekerel B.E., Civelek E., Karabulut E., et al. Are risk factors of childhood asthma predicting disease persistence in early adulthood different in the developing world?. Allergy 61 (2006) 869-877
10. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., and Martinez F.D. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 162 (2000) 1403-1406
11. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics 2002. National Institutes of Health (NIH) Publication No. 02-5074. Bethesda, Md: National Heart, Lung, and Blood Institute (NHLBI); 2002.
12. Stern D.A., Morgan W.J., Wright A.L., et al. Poor airway function in early infancy and lung function by age 22 years: A non-selective longitudinal cohort study. Lancet 370 (2007) 758-764
13. Prescott S.L. The development of respiratory inflammation in children. Paediatr Respir Rev 7 (2006) 89-96
14. Silvestri M., Sabatini F., Defilippi A.C., and Rossi G.A. The wheezy infant-immunological and molecular considerations. Pediatr Respir Rev 5 Suppl A (2004) S81-S87
15. Holgate S.T. Rhinoviruses in the pathogenesis of asthma: The bronchial epithelium as a major disease target. J Allergy Clin Immunol 118 (2006) 587-590
16. Kraft M. The role of bacterial infections in asthma. Clin Chest Med 21 (2000) 301-313
17. Yoshihara S., Yamada Y., Abe T., et al. Association of epithelial damage and signs of neutrophil mobilization in the airways during acute exacerbations of paediatric asthma. Clin Exp Immunol 144 (2006) 212-216
18. Velissariou I.M., and Papadopoulos N.G. The role of respiratory viruses in the pathogenesis of pediatric asthma. Pediatr Ann 35 (2006) 637-642
19. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). National Institutes of Health. NIH Publication No. 02-3659. Bethesda, Md: National Heart, Lung, and Blood Institute (NHLBI); 2005.
20. O'Connell E.J. Pediatric allergy: A brief review of risk factors associated with developing allergic disease in childhood. Ann Allergy Asthma Immunol 90 Suppl 3 (2003) 53-58
21. Koppelman G.H. Gene by environment interaction in asthma. Curr Allergy Asthma Rep 6 (2006) 103-111
22. Nepomnyaschy L., and Reichman N.E. Low birthweight and asthma among young urban children. Am J Public Health 96 (2006) 1604-1610
23. Torrent M., Sunyer J., Muñoz L., et al. Early-life domestic aeroallergen exposure and IgE sensitization at age 4 years. J Allergy Clin Immunol 118 (2006) 742-748
24. Pocket guide for asthma management and prevention in children. Global Initiative for Asthma (GINA). National Institutes of Health. NIH Publication No. 02-3659 Bethesda, Md: National Heart, Lung, and Blood Institute (NHLBI); 2005.
25. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, Full Report 2007. Bethesda, Md: National Heart, Lung, and Blood Institute; August 2007. NIH Publication 07-4051.
26. (September 10, 2007). http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm Accessed
27. Gaglani M.J. Rationale and approach to target children with asthma for annual influenza immunization. Semin Pediatr Infect Dis 13 (2002) 97-103
28. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55 (2006) 1-40
29. Chipps B.E. How pediatric and adult asthma differ, with implications for treatment. Respiratory Digest 9 (2007) 3-13
30. Lemanske R.F., Jackson D.J., Gangnon R.E., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116 (2005) 571-577
31. Boehmer A.L., and Merkus P.J. Asthma therapy for children under 5 years of age. Curr Opin Pulm Med 12 (2006) 34-41
32. Bacharier L.B., Phillips B.R., Bloomberg G.R., et al. Severe intermittent wheezing in preschool children: A distinct phenotype. J Allergy Clin Immunol 119 (2007) 604-610
33. Fiocchi A., Terracciano L., Martelli A., et al. The natural history of childhood-onset asthma. Allergy Asthma Proc 27 (2006) 178-185
34. . Global strategy for asthma management and prevention. Global Initiative for Asthma; 2006.
35. (January 5, 2007). http://www.ginasthma.org Accessed
36. Walsh-Kelly C.M., Drendel A.L., Gales M.S., and Kelly K.J. Childhood asthma in the emergency department: Trends, challenges, and opportunities. Curr Allergy Asthma Rep 6 (2006) 462-467
37. O'Byrne P.M., Bisgaard H., Godard P.P., et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171 (2005) 129-136
38. Yawn B.P., Brennemen S.K., Allen-Ramey F.C., et al. Assessment of asthma severity and asthma control in children. Pediatrics 118 (2006) 322-329
39. Buchvald F., Hermansen M.N., Nielsen K.G., and Bisgaard H. Exhaled nitric oxide predicts exercise-induced bronchoconstriction in asthmatic school children. Chest 128 (2005) 1964-1967
40. Allen D.B. Inhaled steroids for children: Effects on growth, bone, and adrenal function. Endocrinol Metab Clin North Am 34 (2005) 555-564
41. Humbert M. Ciclesonide: A novel inhaled corticosteroid. Expert Opin Investig Drugs 13 (2004) 1349-1360
42. Pharmaceutical Research and Manufacturers of America. Medicines in development for children. 2004. Washington, DC.
43. (December 2006). http://www.phrma.org/new_medicines_in_development_for_children/ Accessed
44. Walker S., Monteil M., Phelan K., et al. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 19 (2006) CD003559
45. Zitt M.J. Properties of the ideal corticosteroid therapy. Allergy Asthma Proc 26 (2005) 173-182
46. Gelfand E.W., Georgitis J.W., Noonan M., and Ruff M.E. Oncedaily ciclesonide in children: Efficacy and safety in asthma. J Pediatr 148 (2006) 377-383
47. Pedersen S., Garcia M.L., Manjra A., et al. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. Pediatr Pulmonol 41 (2006) 954-961
48. Agertoft L., and Pedersen S. Short-term long-leg growth rate and urine cortisol excretion in children treated with ciclesonide. J Allergy Clin Immunol 115 (2005) 940-945
49. Blaiss M.S. Asthma disease management: A critical analysis. Ann Allergy Asthma Immunol 95 Suppl 1 (2005) S106